Concepts (179)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Delirium | 8 | 2022 | 208 | 2.950 |
Why?
|
| Palliative Care | 28 | 2020 | 2175 | 2.530 |
Why?
|
| Hospital Mortality | 8 | 2018 | 1233 | 1.690 |
Why?
|
| Cancer Care Facilities | 11 | 2020 | 907 | 1.570 |
Why?
|
| Emergency Service, Hospital | 11 | 2022 | 1256 | 1.410 |
Why?
|
| Dyspnea | 9 | 2022 | 420 | 1.350 |
Why?
|
| Neoplasms | 26 | 2022 | 15931 | 1.180 |
Why?
|
| Intensive Care Units | 4 | 2016 | 731 | 1.000 |
Why?
|
| Length of Stay | 9 | 2021 | 1997 | 0.820 |
Why?
|
| Hospice and Palliative Care Nursing | 2 | 2020 | 57 | 0.820 |
Why?
|
| Hospice Care | 3 | 2020 | 163 | 0.720 |
Why?
|
| Death | 2 | 2020 | 129 | 0.670 |
Why?
|
| Terminal Care | 4 | 2020 | 466 | 0.630 |
Why?
|
| Hospitalization | 8 | 2022 | 2170 | 0.590 |
Why?
|
| Critical Illness | 2 | 2013 | 734 | 0.560 |
Why?
|
| Haloperidol | 1 | 2017 | 70 | 0.560 |
Why?
|
| Advance Directives | 1 | 2017 | 89 | 0.550 |
Why?
|
| Cultural Diversity | 1 | 2016 | 83 | 0.530 |
Why?
|
| Empathy | 1 | 2016 | 103 | 0.510 |
Why?
|
| Respiratory System Agents | 1 | 2015 | 9 | 0.500 |
Why?
|
| Milrinone | 1 | 2015 | 31 | 0.490 |
Why?
|
| Antipsychotic Agents | 2 | 2017 | 429 | 0.490 |
Why?
|
| Resuscitation Orders | 1 | 2015 | 70 | 0.480 |
Why?
|
| Oncologists | 1 | 2016 | 136 | 0.470 |
Why?
|
| Referral and Consultation | 3 | 2018 | 930 | 0.450 |
Why?
|
| Patient Discharge | 3 | 2018 | 699 | 0.430 |
Why?
|
| Health Services Accessibility | 2 | 2016 | 819 | 0.400 |
Why?
|
| Hemoptysis | 1 | 2011 | 42 | 0.390 |
Why?
|
| Attitude of Health Personnel | 2 | 2015 | 899 | 0.360 |
Why?
|
| Cough | 1 | 2011 | 125 | 0.360 |
Why?
|
| Hypnotics and Sedatives | 2 | 2008 | 211 | 0.340 |
Why?
|
| Benzodiazepines | 1 | 2010 | 166 | 0.330 |
Why?
|
| Mental Recall | 1 | 2009 | 177 | 0.300 |
Why?
|
| Respiratory Tract Neoplasms | 1 | 2007 | 40 | 0.290 |
Why?
|
| Critical Care | 3 | 2010 | 794 | 0.280 |
Why?
|
| Physicians | 1 | 2015 | 853 | 0.270 |
Why?
|
| Humans | 46 | 2022 | 270602 | 0.270 |
Why?
|
| Middle Aged | 26 | 2020 | 90450 | 0.240 |
Why?
|
| Family | 2 | 2020 | 782 | 0.230 |
Why?
|
| Physician's Role | 1 | 2006 | 228 | 0.230 |
Why?
|
| Quality of Health Care | 2 | 2020 | 614 | 0.230 |
Why?
|
| Lung Neoplasms | 2 | 2020 | 12038 | 0.230 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2007 | 562 | 0.220 |
Why?
|
| Methadone | 1 | 2005 | 213 | 0.220 |
Why?
|
| Medication Errors | 1 | 2005 | 189 | 0.220 |
Why?
|
| Aged | 20 | 2018 | 73534 | 0.220 |
Why?
|
| Female | 29 | 2020 | 148790 | 0.220 |
Why?
|
| Male | 28 | 2022 | 128395 | 0.220 |
Why?
|
| Prospective Studies | 6 | 2022 | 13413 | 0.220 |
Why?
|
| Patient-Centered Care | 1 | 2006 | 318 | 0.210 |
Why?
|
| Stress, Psychological | 2 | 2011 | 1038 | 0.210 |
Why?
|
| Patient Admission | 1 | 2004 | 231 | 0.210 |
Why?
|
| Caregivers | 1 | 2009 | 758 | 0.200 |
Why?
|
| Alcoholism | 1 | 2005 | 333 | 0.200 |
Why?
|
| Respiratory Insufficiency | 1 | 2005 | 343 | 0.200 |
Why?
|
| Heart Failure | 1 | 2015 | 2324 | 0.200 |
Why?
|
| Analgesics, Opioid | 3 | 2015 | 1467 | 0.190 |
Why?
|
| Acute Pain | 1 | 2022 | 49 | 0.190 |
Why?
|
| Inpatients | 3 | 2018 | 685 | 0.190 |
Why?
|
| Carotid Artery Diseases | 1 | 2022 | 176 | 0.180 |
Why?
|
| Health Care Rationing | 1 | 2020 | 80 | 0.170 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2008 | 1300 | 0.170 |
Why?
|
| Texas | 7 | 2011 | 6445 | 0.170 |
Why?
|
| Pain, Intractable | 2 | 2011 | 180 | 0.150 |
Why?
|
| Logistic Models | 2 | 2018 | 3429 | 0.140 |
Why?
|
| Retrospective Studies | 12 | 2021 | 39922 | 0.140 |
Why?
|
| Risperidone | 1 | 2017 | 62 | 0.140 |
Why?
|
| Oxygen | 1 | 2020 | 786 | 0.130 |
Why?
|
| Treatment Outcome | 2 | 2015 | 33811 | 0.130 |
Why?
|
| Aged, 80 and over | 10 | 2016 | 31084 | 0.130 |
Why?
|
| China | 1 | 2017 | 627 | 0.130 |
Why?
|
| Medical Oncology | 2 | 2017 | 1464 | 0.120 |
Why?
|
| Minority Groups | 1 | 2016 | 325 | 0.120 |
Why?
|
| Adult | 13 | 2016 | 81960 | 0.110 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 850 | 0.110 |
Why?
|
| United States | 4 | 2020 | 15827 | 0.110 |
Why?
|
| Fatal Outcome | 3 | 2012 | 818 | 0.110 |
Why?
|
| Anesthetics, Dissociative | 1 | 2012 | 23 | 0.100 |
Why?
|
| Young Adult | 5 | 2016 | 22219 | 0.100 |
Why?
|
| Leukemia, Monocytic, Acute | 1 | 2012 | 32 | 0.100 |
Why?
|
| Prognosis | 4 | 2019 | 22520 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2012 | 203 | 0.100 |
Why?
|
| Pain Management | 2 | 2022 | 716 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2012 | 413 | 0.090 |
Why?
|
| Injections, Subcutaneous | 1 | 2010 | 341 | 0.090 |
Why?
|
| Professional-Family Relations | 1 | 2011 | 132 | 0.090 |
Why?
|
| Hospital Units | 1 | 2009 | 40 | 0.080 |
Why?
|
| Ketamine | 1 | 2012 | 238 | 0.080 |
Why?
|
| Risk Factors | 3 | 2018 | 17855 | 0.080 |
Why?
|
| Chlorpromazine | 1 | 2008 | 20 | 0.080 |
Why?
|
| Lorazepam | 1 | 2008 | 40 | 0.080 |
Why?
|
| Midazolam | 1 | 2008 | 71 | 0.080 |
Why?
|
| ras Proteins | 1 | 2012 | 804 | 0.080 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2010 | 165 | 0.080 |
Why?
|
| Conscious Sedation | 1 | 2008 | 101 | 0.080 |
Why?
|
| Social Support | 1 | 2011 | 585 | 0.070 |
Why?
|
| Oncology Service, Hospital | 1 | 2007 | 49 | 0.070 |
Why?
|
| Survival Analysis | 3 | 2020 | 9281 | 0.070 |
Why?
|
| Translocation, Genetic | 1 | 2012 | 1286 | 0.070 |
Why?
|
| Methylprednisolone | 1 | 2007 | 200 | 0.070 |
Why?
|
| Head and Neck Neoplasms | 1 | 2022 | 4148 | 0.070 |
Why?
|
| Leukemia | 1 | 2015 | 1719 | 0.070 |
Why?
|
| Cohort Studies | 1 | 2018 | 9460 | 0.060 |
Why?
|
| Sertraline | 1 | 2005 | 42 | 0.060 |
Why?
|
| Models, Statistical | 1 | 2011 | 1186 | 0.060 |
Why?
|
| Back Pain | 1 | 2005 | 62 | 0.060 |
Why?
|
| Hyperalgesia | 1 | 2007 | 245 | 0.060 |
Why?
|
| Adolescent | 5 | 2021 | 32684 | 0.060 |
Why?
|
| Drug Interactions | 1 | 2005 | 572 | 0.060 |
Why?
|
| Reimbursement Mechanisms | 1 | 2004 | 76 | 0.060 |
Why?
|
| Hospitals, University | 1 | 2004 | 217 | 0.060 |
Why?
|
| Drug Monitoring | 1 | 2005 | 352 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2012 | 2618 | 0.050 |
Why?
|
| Medical Records | 1 | 2004 | 441 | 0.050 |
Why?
|
| Dexamethasone | 1 | 2007 | 1515 | 0.050 |
Why?
|
| Multivariate Analysis | 1 | 2009 | 4317 | 0.050 |
Why?
|
| Carotid Arteries | 1 | 2022 | 246 | 0.040 |
Why?
|
| Health Planning | 1 | 2020 | 28 | 0.040 |
Why?
|
| Pain | 1 | 2008 | 1701 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2000 | 190 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2020 | 455 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 5056 | 0.040 |
Why?
|
| Loss of Heterozygosity | 1 | 2000 | 623 | 0.040 |
Why?
|
| Syndrome | 1 | 2022 | 1409 | 0.040 |
Why?
|
| Health Care Surveys | 2 | 2010 | 415 | 0.040 |
Why?
|
| Neoplasm Staging | 2 | 2010 | 14021 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2022 | 724 | 0.040 |
Why?
|
| Health Care Costs | 1 | 2022 | 696 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2020 | 536 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 15270 | 0.030 |
Why?
|
| Stents | 1 | 2022 | 1002 | 0.030 |
Why?
|
| Esophageal Neoplasms | 2 | 2000 | 3240 | 0.030 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 1998 | 402 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2020 | 2563 | 0.030 |
Why?
|
| Health Personnel | 1 | 2020 | 650 | 0.030 |
Why?
|
| Alleles | 1 | 2000 | 2597 | 0.030 |
Why?
|
| Laryngeal Neoplasms | 1 | 1998 | 530 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2004 | 4391 | 0.030 |
Why?
|
| Telemedicine | 1 | 2020 | 556 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2000 | 5595 | 0.030 |
Why?
|
| Advance Directive Adherence | 1 | 2012 | 1 | 0.030 |
Why?
|
| Tongue Diseases | 1 | 2012 | 19 | 0.030 |
Why?
|
| Ovarian Neoplasms | 1 | 2008 | 4800 | 0.030 |
Why?
|
| Angioedema | 1 | 2012 | 22 | 0.030 |
Why?
|
| Anesthetics, Intravenous | 1 | 2012 | 70 | 0.030 |
Why?
|
| Mutation | 1 | 2012 | 15905 | 0.030 |
Why?
|
| Nursing Homes | 1 | 2012 | 100 | 0.020 |
Why?
|
| Hydroxyurea | 1 | 2012 | 224 | 0.020 |
Why?
|
| Fentanyl | 1 | 2012 | 152 | 0.020 |
Why?
|
| Antineoplastic Agents | 2 | 2012 | 14638 | 0.020 |
Why?
|
| Pandemics | 1 | 2020 | 1608 | 0.020 |
Why?
|
| Medical Audit | 1 | 2011 | 194 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2015 | 16242 | 0.020 |
Why?
|
| Hospices | 1 | 2010 | 51 | 0.020 |
Why?
|
| Probability | 1 | 2011 | 886 | 0.020 |
Why?
|
| Patient Care Management | 1 | 2010 | 92 | 0.020 |
Why?
|
| Airway Obstruction | 1 | 2012 | 274 | 0.020 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2010 | 219 | 0.020 |
Why?
|
| Neoplasms, Second Primary | 1 | 1998 | 1388 | 0.020 |
Why?
|
| Algorithms | 1 | 2020 | 3906 | 0.020 |
Why?
|
| Psychotherapy | 1 | 2011 | 249 | 0.020 |
Why?
|
| Analgesics | 1 | 2011 | 406 | 0.020 |
Why?
|
| Databases as Topic | 1 | 2007 | 135 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 2009 | 414 | 0.020 |
Why?
|
| Demography | 1 | 2007 | 432 | 0.020 |
Why?
|
| Patient Care Team | 1 | 2011 | 823 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2012 | 1403 | 0.020 |
Why?
|
| Health Services Needs and Demand | 1 | 2007 | 244 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2009 | 1562 | 0.020 |
Why?
|
| Emotions | 1 | 2008 | 558 | 0.020 |
Why?
|
| Models, Biological | 1 | 2010 | 3186 | 0.010 |
Why?
|
| Age Factors | 1 | 2010 | 5441 | 0.010 |
Why?
|
| Microsatellite Repeats | 1 | 2000 | 627 | 0.010 |
Why?
|
| Epiglottis | 1 | 1998 | 13 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2000 | 1647 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2000 | 1471 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2000 | 1557 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2000 | 3464 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 1998 | 4969 | 0.000 |
Why?
|